Related Experiment Video
Updated: Jun 4, 2026
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Targeting integrins in hepatocellular carcinoma
Yanhua Wu1, Xiaojing Qiao, Shouyi Qiao
1Fudan University, Institute of Genetics, State Key Laboratory of Genetic Engineering, 220 Handan Road, Shanghai, 200433, P. R. China.
Expert Opinion on Therapeutic Targets
|February 22, 2011
Summary
Integrins are key cell adhesion molecules implicated in hepatocellular carcinoma (HCC) development. Targeting these integrins shows promise for novel HCC therapies, though tumor heterogeneity requires careful consideration for drug development.
Area of Science:
- Oncology
- Molecular Biology
- Cell Adhesion
Background:
- Integrins are cell-surface receptors crucial for cell adhesion.
- Integrin dysregulation is linked to tumor development, particularly in Hepatocellular Carcinoma (HCC).
- Integrins represent promising therapeutic targets for HCC treatment.
Purpose of the Study:
- To review current knowledge on integrins in HCC.
- To explore the therapeutic potential of integrin-targeted drugs for HCC.
- To discuss the implications of preclinical and clinical trials for integrin-based HCC therapies.
Main Methods:
- Literature review of integrins in HCC.
- Description of integrin structure, function, and regulation.
- Analysis of distinct integrin expression patterns and functions in HCC.
- Discussion of integrin-based therapies in HCC and other cancers.
Main Results:
- Integrins play a significant role in HCC pathogenesis.
- Various integrin-targeted drugs are in development for cancer treatment.
- Preclinical and clinical data inform the potential of these therapies.
Conclusions:
- Integrin-targeted drugs show diverse effects in cancer clinical trials.
- Addressing tumor heterogeneity is crucial for developing effective HCC-specific integrin drugs.
- Understanding integrin cooperation in HCC is vital for designing successful targeted therapies.
More Related Videos
Related Concept Videos
01:15Activation of Integrins
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
01:10Integrins
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:25Selectins
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...